Answers are grounded in this paper and cite their sources.
Background: Tumor Treating Fields (TTFields) are being investigated for pelvic malignancies, while total hip arthroplasty (THA) is increasingly common. This study evaluated whether THA prosthetic materials influence TTFields distribution and target dosimetry in ovarian tumors. Methods: Patient-specific finite element models were generated from computed tomography datasets of four patients with ovarian carcinoma. Three-dimensional simulations assigned cortical bone, Ti6Al4V titanium alloy, Co28Cr6Mo cobalt-chromium alloy, or tantalum to both femurs or to a single femur. Electric field (E), specific absorption rate (SAR), and current density (CD) were quantified in the clinical target volume (CTV), femur, and skin using 95%, 50%, and 5% volume-based metrics. Results: Bilateral implant properties produced minor CTV dosimetric changes, with mean and median percent differences generally within ±3.4% across metrics. Tantalum closely approximated cortical bone, typically within ±1%. Implants substantially reduced femoral E and SAR distributions while increasing CD. Skin exposure decreased modestly across 95% and 50% volumes. Unilateral implants similarly preserved CTV dosimetry within ±5.8%, while the contralateral cortical femur changed by less than 3.2%. Conclusions: In our preliminary analysis, THA materials altered femoral distributions of TTFields while largely preserving relevant CTV dosimetry in both bilateral and unilateral configurations. Tantalum closely approximated cortical bone and produced slightly greater skin reductions.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: